These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32762395)

  • 1. Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study.
    Yang J; Zhou W; Wu Y; Xu L; Wang Y; Xu Z; Yang Y
    J Int Med Res; 2020 Aug; 48(8):300060520935219. PubMed ID: 32762395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
    Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
    Runchey SS; Boyko EJ; Ioannou GN; Utzschneider KM
    J Gastroenterol Hepatol; 2014 Mar; 29(3):589-96. PubMed ID: 24716226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
    Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
    Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.
    Hu D; Pawlikowska L; Kanaya A; Hsueh WC; Colbert L; Newman AB; Satterfield S; Rosen C; Cummings SR; Harris TB; Ziv E;
    J Am Geriatr Soc; 2009 Jul; 57(7):1213-8. PubMed ID: 19558480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.
    Hagström H; Stål P; Hultcrantz R; Brismar K; Ansurudeen I
    Scand J Gastroenterol; 2017 Dec; 52(12):1427-1434. PubMed ID: 28927302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.
    Cianfarani S; Inzaghi E; Alisi A; Germani D; Puglianiello A; Nobili V
    J Pediatr; 2014 Jul; 165(1):92-8. PubMed ID: 24607243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort.
    Martin RM; Holly JM; Davey Smith G; Gunnell D
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3287-95. PubMed ID: 16787980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
    Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study.
    Hu Y; Yuan C; Abdulnaimu M; Memetmin J; Jie Z; Tuhuti A; Abudueini H; Guo Y
    Front Endocrinol (Lausanne); 2024; 15():1290007. PubMed ID: 38370349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CTRP3 level is inversely associated with nonalcoholic fatty liver disease: A 3-y longitudinal study.
    Zhou W; Wang Y; Wu Y; Yang J; Xu L; Yang Y
    Clin Chim Acta; 2018 Apr; 479():79-83. PubMed ID: 29305845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model].
    Zhang Q; Zhang ZX; Fang Q; Gao FY; Zhao QL; Yang Y; Su HM; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):196-200. PubMed ID: 22475139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.